Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- Check4 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the previous content, replacing the detailed study information with a minimal error page.SummaryDifference17%

- Check11 days agoChange DetectedThe page's revision tag changed from v3.6.6 to v3.7.0, representing an update to the page rendering or underlying system. This is a maintenance update and does not modify the study details or results presented on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a new build of the ClinicalTrials.gov page. This is a backend update that does not change the study details or data shown for NCT04541043.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the underlying version without altering displayed study information.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now shows revision v3.6.4, replacing v3.6.3. This appears to be a minor maintenance update without changes to study content or eligibility details.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, indicating a minor update to the study details page.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.